Maven Bio YC 申请

Summer 2023Active

Maven Bio 在 Summer 2023 批次的 Y Combinator 中作为一家 B2B 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2023
行业: B2B
团队规模: 8
状态: Active
已发布: 2023

创始人

Michael BradyFounder
Arjun MurthyFounder

Maven Bio 做什么

At Maven Bio, we’re transforming BioPharma knowledge work by pairing domain-specific AI with curated industry data - letting consultants, investors, and corporate teams move from question to decision with less manual work. Our integrated BioPharma-specific platform features four flagship modules: • Maven Workflows: Monitor Maven's domain-specific AI through structured research tasks - step by step - and finalize results with confidence. • Maven Atlas: Access hundreds of pre-built indication landscapes, or generate custom ones on demand for in-depth insights. • Maven Compass: Build precise lists of companies, drugs, trials, or documents with advanced filters - move faster with AI-driven filter suggestions. • Maven Assistant: Get instant answers to your BioPharma questions, complete with direct links to primary sources. Stop burning hours on manual data hunts. Maven Bio’s continuously updated database and collaborative AI features empower you to focus on strategic decisions. We offer usage-based pricing and usage-restricted trials, plus custom solutions for unique data sources or specialized workflows. Trusted by life science consultants, BD teams, and investors worldwide, Maven Bio delivers faster, deeper insights. Book a call to learn how our purpose-built AI can transform your research and accelerate your success.

Maven Bio 的 YC 申请，重建版

Y Combinator 申请

Maven Bio，Summer 2023 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Maven Bio

Describe what your company does in 50 characters or less.

The AI Platform for Life Sciences Intelligence

What is your company going to make? Please describe your product and what it does or will do.

We build an AI platform focused on BioPharma research. Our product combines domain-specific AI with curated datasets to help consultants, investors, and corporate teams quickly find reliable insights on drugs, trials, companies, and indications. It includes four main modules: structured workflows to monitor AI-driven research, pre-built and custom indication maps, AI-assisted filtering for lists, and a bio-pharma question-answering assistant.

Where do you live now, and where would the company be based after YC?

We live in Boston, MA and the company is based here and will remain so after YC.

Explain your decision regarding location.

Boston has strong biotech and pharma hubs and access to domain experts. Being here helps us stay close to early customers and industry partners.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Maven Bio 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Maven Bio 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Maven Bio 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Maven Bio 是哪个 YC 批次的？

Maven Bio 是 Y Combinator Summer 2023 批次的成员。

谁创立了 Maven Bio？

Maven Bio 由 Michael Brady, Arjun Murthy 创立。

Maven Bio 做什么？